After trying antidepressants, attending therapy, and doing everything you can to feel better, persistent depression can feel especially discouraging. For adults seeking Spravato treatment for resistant depression in Michigan, a different approach may offer renewed hope when standard treatments have not provided enough relief.
Spravato is not a replacement for compassionate psychiatric care, ongoing therapy, or a carefully considered medication plan. It is a specialized, FDA-approved treatment that may be appropriate for some adults with treatment-resistant depression. Understanding how it works, who may qualify, and what treatment involves can make the next step feel more manageable.
What Is Spravato?
Spravato is the brand name for esketamine, a nasal spray used under medical supervision to treat treatment-resistant depression in adults. It is related to ketamine but is a distinct, FDA-approved medication with specific safety and monitoring requirements.
Most antidepressants work primarily through serotonin, norepinephrine, or similar brain chemical pathways. Spravato works differently, affecting the glutamate system. Researchers believe this action may help some people whose depression has continued despite trying traditional antidepressant medications.
It is used alongside an oral antidepressant, not as a stand-alone treatment. That distinction matters. A thoughtful treatment plan considers your medication history, current symptoms, medical needs, therapy support, and day-to-day circumstances rather than relying on one intervention alone.
When Is Depression Considered Treatment-Resistant?
Treatment-resistant depression does not mean a person has failed treatment or cannot get better. It is a clinical term that generally describes major depression that has not improved enough after trials of at least two antidepressant medications taken at an appropriate dose and for an appropriate length of time.
The details matter. A medication may not have worked because of difficult side effects, an inadequate dose, missed doses, a co-occurring condition, or because it simply was not the right fit. Before recommending Spravato, a psychiatric provider should review prior medications carefully and assess factors that can affect depression, including anxiety, trauma, substance use, sleep concerns, medical conditions, and bipolar-spectrum symptoms.
For some people, psychotherapy and medication adjustments remain the best next step. For others, Spravato may be a reasonable option after a complete evaluation. The goal is not to place a label on someone’s depression. The goal is to find a path forward that is tailored to their needs.
What Spravato Treatment in Michigan Involves
Spravato is given at a certified treatment center, not dispensed for use at home. During an appointment, the patient administers the nasal spray under the direction of trained clinical staff. They then remain at the center for monitoring for at least two hours.
This observation period is required because Spravato can temporarily cause sleepiness, dizziness, dissociation, changes in blood pressure, nausea, or a sense of feeling detached from oneself or surroundings. These effects often lessen during the observation period, but they are why the treatment must take place in a monitored setting.
Patients should arrange transportation home after every session. They should not drive, operate machinery, or make safety-sensitive decisions until the next day after a restful night of sleep. Planning for this practical detail ahead of time helps treatment days feel calmer and safer.
Treatment is often more frequent at the beginning and may become less frequent over time, depending on response and the prescribing provider’s plan. Some people notice improvement relatively early, while others need more time or may not experience the level of benefit they hoped for. Honest follow-up conversations are essential throughout care.
Who May Be a Good Candidate?
A psychiatric evaluation is the right place to determine whether Spravato fits your situation. Candidates are adults with treatment-resistant depression who can attend monitored visits and continue an oral antidepressant as prescribed.
Your provider will also discuss your health history and any concerns that could change the risk-benefit decision. Blood pressure needs particular attention because Spravato can temporarily raise it. A history of certain blood vessel conditions, some heart-related concerns, pregnancy considerations, substance use history, or symptoms of psychosis may require added caution or point toward another treatment approach.
This is not meant to be a barrier to care. It is part of responsible psychiatric treatment. The most helpful plan is one that considers the whole person, including physical health, family responsibilities, work demands, emotional safety, and access to ongoing support.
Spravato Is Not a Crisis Substitute
Depression can include thoughts of self-harm or suicide, and those thoughts deserve immediate attention. Spravato treatment is scheduled outpatient care, not emergency intervention. If someone is in immediate danger or unable to stay safe, they should call 911, go to the nearest emergency department, or call or text 988 for the Suicide & Crisis Lifeline.
A provider can help build a treatment plan for ongoing depression, but urgent safety needs should always come first.
Why Ongoing Psychiatric Support Matters
Spravato works best as part of comprehensive care. Depression rarely exists in isolation. It can affect sleep, relationships, concentration, appetite, work, parenting, and a person’s confidence in their ability to cope. Therapy can help patients address patterns of thinking and behavior, process difficult experiences, and build skills that support progress between appointments.
Medication management also remains important. Your provider will monitor the oral antidepressant used with Spravato, watch for side effects, assess symptom changes, and adjust the plan when needed. For people with anxiety, trauma, ADHD, substance use concerns, or other mental health needs, coordinated care can prevent treatment from becoming fragmented.
At SmartMinds Psychiatry in Grand Rapids, this whole-person approach can include psychiatric evaluation, medication management, psychotherapy, and support for related mental health concerns. Having care coordinated in one outpatient setting can make it easier to understand what is working and what needs to change.
Questions to Ask Before Starting Spravato
The decision to begin Spravato should feel informed, not rushed. Ask your provider why they believe it may be appropriate based on your medication history and symptoms. It is also reasonable to ask what changes would count as meaningful improvement, how your progress will be measured, and what alternatives remain available if Spravato is not the right fit.
Practical questions are equally valuable. Ask about appointment frequency, how long each visit will take, transportation requirements, potential side effects, work scheduling, and whether a support person should be involved. If cost is a concern, ask how insurance authorization works and what your specific plan may require.
Many insurance plans, including Medicare and Medicaid plans, may provide coverage for Spravato when clinical and authorization requirements are met. Coverage varies by plan, so it is best to verify benefits, prior authorization requirements, and any out-of-pocket responsibility before treatment begins.
Frequently Asked Questions About Spravato Treatment-Resistant Depression in Michigan
Does Spravato cure depression?
No treatment can promise a cure for every person. Spravato may reduce depressive symptoms for some eligible adults, but results vary. Continued medication management, therapy, healthy routines, and regular communication with your provider can all play a role in maintaining progress.
Will I feel different during the appointment?
Some patients experience temporary dizziness, drowsiness, nausea, or dissociation. People often describe dissociation as feeling unusual, detached, or as though their perception has shifted for a short time. Clinical staff monitor patients throughout the required observation period and can address concerns as they arise.
Can I work after a Spravato session?
You should plan not to return to work that day if your work involves driving, operating equipment, caring for others alone, or making important decisions. Because people respond differently, it is wise to keep the remainder of the day low-pressure and arrange a ride home in advance.
Depression that has not responded to prior treatment can make hope feel distant, but it does not mean you are out of options. A careful psychiatric evaluation can help clarify whether Spravato or another personalized treatment path may be a meaningful next step.